These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 14709651)

  • 1. Effects of concentration and temperature on the stability of nevirapine in whole blood and serum.
    Bennetto CJ; King JR; Turner ML; Stringer JS; Acosta EP
    Clin Chem; 2004 Jan; 50(1):209-11. PubMed ID: 14709651
    [No Abstract]   [Full Text] [Related]  

  • 2. An LC-MS-MS method for the determination of nevirapine, a non-nucleoside reverse transcriptase inhibitor, in human plasma.
    Chi J; Jayewardene AL; Stone JA; Aweeka FT
    J Pharm Biomed Anal; 2003 Apr; 31(5):953-9. PubMed ID: 12684107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical guidelines to interpret plasma concentrations of antiretroviral drugs.
    Leith J; Hinzmann R; Mayers D
    Clin Pharmacokinet; 2005; 44(4):439; author reply 439-40. PubMed ID: 15828857
    [No Abstract]   [Full Text] [Related]  

  • 4. St. John's wort found to lower nevirapine levels.
    TreatmentUpdate; 2001; 12(11):6. PubMed ID: 11570073
    [No Abstract]   [Full Text] [Related]  

  • 5. Sex differences in nevirapine disposition in HIV-infected patients.
    Regazzi M; Villani P; Seminari E; Ravasi G; Cusato M; Marubbi F; Meneghetti G; Maserati R
    AIDS; 2003 Nov; 17(16):2399-400. PubMed ID: 14571195
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detection.
    van Heeswijk RP; Hoetelmans RM; Meenhorst PL; Mulder JW; Beijnen JH
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):395-9. PubMed ID: 9746255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic of nevirapine in haemodialysis.
    Izzedine H; Launay-Vacher V; Aymard G; Legrand M; Deray G
    Nephrol Dial Transplant; 2001 Jan; 16(1):192-3. PubMed ID: 11209031
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver toxicity caused by nevirapine.
    González de Requena D; Núñez M; Jiménez-Nácher I; Soriano V
    AIDS; 2002 Jan; 16(2):290-1. PubMed ID: 11807315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
    Jackson JB; Parsons T; Musoke P; Nakabiito C; Donnell D; Fleming T; Mirochnick M; Mofenson L; Fowler MG; Mmiro F; Guay L
    AIDS; 2006 Jan; 20(2):217-22. PubMed ID: 16511414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.
    Shapiro RL; Holland DT; Capparelli E; Lockman S; Thior I; Wester C; Stevens L; Peter T; Essex M; Connor JD; Mirochnick M
    J Infect Dis; 2005 Sep; 192(5):720-7. PubMed ID: 16088821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals.
    Veldkamp AI; Weverling GJ; Lange JM; Montaner JS; Reiss P; Cooper DA; Vella S; Hall D; Beijnen JH; Hoetelmans RM
    AIDS; 2001 Jun; 15(9):1089-95. PubMed ID: 11416710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individuals.
    Almond LM; Edirisinghe D; Dalton M; Bonington A; Back DJ; Khoo SH
    Clin Pharmacol Ther; 2005 Aug; 78(2):132-42. PubMed ID: 16084848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of nevirapine in plasma by GC-MS.
    Vogel M; Bertram N; Wasmuth JC; Emmelkamp J; Rockstroh JK; Reichel C
    J Chromatogr Sci; 2010 Feb; 48(2):91-4. PubMed ID: 20109283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of abacavir, amprenavir, didanosine, efavirenz, nevirapine, and stavudine concentration in human plasma by MALDI-TOF/TOF.
    Notari S; Mancone C; Alonzi T; Tripodi M; Narciso P; Ascenzi P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 863(2):249-57. PubMed ID: 18258495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efavirenz and nevirapine in HIV-1 infection : is there a role for clinical pharmacokinetic monitoring?
    Dahri K; Ensom MH
    Clin Pharmacokinet; 2007; 46(2):109-32. PubMed ID: 17253884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonnucleoside reverse transcriptase inhibitor fold change or plasma concentration as a predictor of virological response over 48 weeks in highly treatment experienced HIV-positive individuals.
    Winston A; Amin J; Hales G; Cooper DA; Emery S
    AIDS Res Hum Retroviruses; 2006 Apr; 22(4):338-41. PubMed ID: 16623637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined-formulation tablet of lamivudine/nevirapine/stavudine: bioequivalence compared with concurrent administration of lamivudine, nevirapine, and stavudine in healthy Indian subjects.
    Narang VS; Lulla A; Malhotra G; Purandare S
    J Clin Pharmacol; 2005 Mar; 45(3):265-74. PubMed ID: 15703362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in nevirapine plasma concentrations over time and its relationship with liver enzyme elevations.
    De Requena DG; Jiménez-Nácher I; Soriano V
    AIDS Res Hum Retroviruses; 2005 Jun; 21(6):555-9. PubMed ID: 15989460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Nevirapine levels in the blood found higher in women.
    TreatmentUpdate; 2003; 15(3):2. PubMed ID: 17216844
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of nevirapine: once-daily versus twice-daily dosing in the 2NN study.
    Kappelhoff BS; Huitema AD; van Leth F; Robinson PA; MacGregor TR; Lange JM; Beijnen JH;
    HIV Clin Trials; 2005; 6(5):254-61. PubMed ID: 16306032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.